Urteste S.A. (URT) Price & Analysis

0 Followers

URT Stock Chart & Stats

zł34.30

Market closed

zł34.30

Day’s Range― - ―

52-Week Rangezł24.00 - zł72.20

Previous CloseN/A

VolumeN/A

Average Volume (3M)685.00

Market Cap

zł66.38M

Enterprise Valuezł71.08M

Total Cash (Recent Filing)zł7.60M

Total Debt (Recent Filing)zł2.90M

Price to Earnings (P/E)―

Beta0.73

Next Earnings

Sep 29, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-4.94

Shares Outstanding1,526,080

10 Day Avg. Volume467

30 Day Avg. Volume685

Financial Highlights & Ratios

PEG Ratio-0.14

Price to Book (P/B)2.21

Price to Sales (P/S)2500.63

P/FCF Ratio5.29

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Urteste S.A. News

Urteste’s Panuri Trial Targets Earlier Pancreatic Cancer Detection, Setting Up a Key Catalyst for URT Investors

Urteste S.A. ($PL:URT) announced an update on their ongoing clinical study. The Panuri Performance Study, officially titled “Evaluation...

4M ago

URT

URT FAQ

What was Urteste S.A.’s price range in the past 12 months?

Urteste S.A. lowest stock price was zł24.00 and its highest was zł72.20 in the past 12 months.

What is Urteste S.A.’s market cap?

Urteste S.A.’s market cap is zł66.38M.

When is Urteste S.A.’s upcoming earnings report date?

Urteste S.A.’s upcoming earnings report date is Sep 29, 2026 which is in 14 days.

How were Urteste S.A.’s earnings last quarter?

Urteste S.A. released its earnings results on Apr 29, 2026. The company reported -zł1.217 earnings per share for the quarter.

Is Urteste S.A. overvalued?

According to Wall Street analysts Urteste S.A.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Urteste S.A. pay dividends?

Urteste S.A. does not currently pay dividends.

What is Urteste S.A.’s EPS estimate?

Urteste S.A.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Urteste S.A. have?

Urteste S.A. has 1,526,080 shares outstanding.

What happened to Urteste S.A.’s price movement after its last earnings report?

Urteste S.A. reported an EPS of -zł1.217 in its last earnings report. Following the earnings report the stock price went up 3.8%.

Which hedge fund is a major shareholder of Urteste S.A.?

Currently, no hedge funds are holding shares in PL:URT

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Urteste S.A.

Urteste S.A. focuses on the investigation and development of diagnostic solutions designed to detect various forms of cancer. Their portfolio includes testing methods for a wide range of malignancies affecting organs such as the pancreas, prostate, kidneys, colon, liver, biliary system, stomach, lungs, esophagus, ovaries, endometrium, blood, breasts, and the nervous system. This enterprise, based in Gdansk, Poland, commenced its operations in 2021.